Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
113 results
  1. NLM Digital Collections - Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 17, 2022
    resource.nlm.nih.gov/9918506285006676
    ... Review, 2022 Page 35 Revised Report - Chemotherapy-Induced Neutropenia Return to Table of Contents References 10. 11. 12. 13. 14. 15. 16. Barreto ... Review, 2022 Page D6 Revised Report - Chemotherapy-Induced Neutropenia Return to ... 131 references 5 references identified identified through through other sources ...
  2. NLM Digital Collections - Index-catalogue of the Library of the Surgeon General's Office, United States Army (Series 4, ... 
    Publication: Washington : U.S. G.P.O., 1936-1948
    resource.nlm.nih.gov/8104688X1
    ... T. The clinical significance of leucopenia with special reference to idiopathic neutropenia. Ann. Int. M, Ann Arbor, 1932, 6: 855- ...
  3. NLM Digital Collections - Medicare Part D and beneficiaries could realize significant spending reductions with ... 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2022
    resource.nlm.nih.gov/9918434087206676
    ... colitis; anemia due to chronic kidney disease; and neutropenia, when the body makes too few white blood cells as a result of chemotherapy. Part D and beneficiary spending on these biosimilars and their reference products was about $466 million.°° Exhibit 1 lists ...
  4. NLM Digital Collections - Health Care Reform 
    https://resource.nlm.nih.gov/101662437X856
    ... CunningHAM, M.D. NorMmaN F. Gant, M.D. REFERENCES 1. Koenig JM, Christensen RD. Incidence, neutrophil kinetics, and natural his- tory of neonatal neutropenia associated with maternal hypertension. N Engl J Med ...
  5. NLM Digital Collections - Tomorrow's Medicine 
    https://resource.nlm.nih.gov/101662437X876
    ... Diflucan prophylaxis several days before anticipated onset of neutropenia. ... not recommended. ‘References: 1. Data available on request from Roerig. 2. ...
  6. NLM Digital Collections - Economic analysis of availability of follow-on protein products : final report 
    Publication: [Washington, DC] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2009
    resource.nlm.nih.gov/101615134
    ... alphas: “a randomised, parallel group comparison against the reference product” 136  For granulocyte stimulating factors: a “two-arm comparability study in chemotherapy regimens with known frequency and duration of severe neutropenia”; at least 6 months safety data from a ...
  7. NLM Digital Collections - Briefing Book, 1989-1990 
    https://resource.nlm.nih.gov/101083016X51
    ... studied for the treat- ment of AZT-related neutropenia. mBACOD: ACTG Trial ... in the Physician’s Desk Reference (PDR). GM-CSF is given to pa- tients ...
  8. NLM Digital Collections - A bibliographical sourcebook of compressed air, diving, and submarine medicine (Volume 2) 
    Publication: Washington, D.C. : Research Division, Project X-427, Bureau of Medicine and Surgery, Navy Department, 1948-1966
    resource.nlm.nih.gov/59820860RX2
    ... studies on 20 Nagasaki patients demonstrated an anemia, neutropenia, and throm- bycytopenia. Seven post-morten examinations con- ...
  9. Browse: Guide to Mental Health Motion Pictures 
    https://www.nlm.nih.gov/.../films/mentalhealthguide/guide.html
    ... 5. Title: Acute schizophrenic episode: differential diagnosis: migraine, neutropenia, secondary to unknown drugs Date: 1969 Run Time: ... the points of differentiation between them with special reference to their etiology. Included are: generalized tic or ...
  10. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    ... PARP inhibitors are nausea, vomiting, anemia, thrombocytopenia, and neutropenia. The most serious complications are myelodysplastic syndrome and ... and reported rates of both grade 3-4 neutropenia (20%) and thrombocytopenia (34%) were also considerably higher ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last